Importance of sequence in rescheduling bevacizumab and FOLFOX-4 regimen as a first-line treatment in patients with metastatic colorectal carcinoma (mCRC).
Phase of Trial: Phase II
Latest Information Update: 23 Dec 2015
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 23 Dec 2015 New trial record